SpiderRock Advisors’s Eli Lilly LLY Stock Holding History

SpiderRock Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$38.6M	Buy	43,600 +6,500	+18%	+$5.84M	0.61%	27
2024 Q2	$33.6M	Sell	37,100 -5,100	-12%	-$4.08M	0.67%	25
2024 Q1	$32.2M	Buy	+42,200	New	+$30M	0.8%	23
2023 Q4	–	Hold	0	–	–	–	6
2023 Q3	–	Hold	0	–	–	–	11
2023 Q2	–	Hold	0	–	–	–	21
2023 Q1	–	Hold	0	–	–	–	19
2022 Q4	–	Hold	0	–	–	–	23
2022 Q3	–	Hold	0	–	–	–	13
2022 Q2	–	Hold	0	–	–	–	10
2022 Q1	–	Hold	0	–	–	–	11
2021 Q4	–	Hold	0	–	–	–	13
2021 Q3	–	Hold	0	–	–	–	13
2021 Q2	–	Hold	0	–	–	–	14
2021 Q1	–	Hold	0	–	–	–	15
2020 Q4	–	Hold	0	–	–	–	10
2020 Q3	–	Hold	0	–	–	–	8
2020 Q2	–	Hold	0	–	–	–	6
2020 Q1	–	Hold	0	–	–	–	3
2019 Q4	–	Hold	0	–	–	–	78
2019 Q3	–	Hold	0	–	–	–	48
2019 Q2	–	Hold	0	–	–	–	44
2019 Q1	–	Hold	0	–	–	–	41
2018 Q4	–	Hold	0	–	–	–	23
2017 Q4	–	Hold	0	–	-$12K	–	240
2017 Q3	–	Hold	0	–	–	–	405
2017 Q2	–	Hold	0	–	–	–	145
2017 Q1	–	Hold	0	–	–	–	316

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

SpiderRock Advisors's LLY Position: Q3 2024 in Review

SpiderRock Advisors increased its Eli Lilly (LLY) stake by 8.2% in Q3 2024, buying an estimated $5.69M and bringing the position to 83,368 shares worth $73.9M. The position accounts for 1.18% of the portfolio, ranked #15.

SpiderRock Advisors first reported a position in LLY in Q1 2024 and has held it in 3 quarters since. 3,657 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

SpiderRock Advisors held 83,368 shares of Eli Lilly worth $73.9M as of Q3 2024.
SpiderRock Advisors bought 6,331 Eli Lilly shares in Q3 2024, an estimated $5.69M.
Eli Lilly made up 1.18% of SpiderRock Advisors's portfolio in Q3 2024, its #15 holding.
SpiderRock Advisors first reported a position in Eli Lilly in Q1 2024 and has held it in 3 quarters since.
3,657 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on SpiderRock Advisors's 13F filing for Q3 2024, filed 1 Nov 2024.